Business Description
Windlas Biotech Ltd
ISIN : INE0H5O01029
Compare
Compare
Traded in other countries / regions
543329.India IPO Date
2021-08-16Description
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 56.13 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | 48.16 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 8.93 | |||||
| Beneish M-Score | -2.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32 | |||||
| 3-Year EBITDA Growth Rate | 58.4 | |||||
| 3-Year EPS without NRI Growth Rate | 15.1 | |||||
| 3-Year FCF Growth Rate | 170.7 | |||||
| 3-Year Book Growth Rate | 33.3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.35 | |||||
| 9-Day RSI | 58.28 | |||||
| 14-Day RSI | 59.21 | |||||
| 6-1 Month Momentum % | 61.52 | |||||
| 12-1 Month Momentum % | 128.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 2.15 | |||||
| Cash Ratio | 1.19 | |||||
| Days Inventory | 58.18 | |||||
| Days Sales Outstanding | 70.23 | |||||
| Days Payable | 95.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.45 | |||||
| Dividend Payout Ratio | 0.14 | |||||
| Forward Dividend Yield % | 0.62 | |||||
| 5-Year Yield-on-Cost % | 0.45 | |||||
| 3-Year Average Share Buyback Ratio | 1.5 | |||||
| Shareholder Yield % | 0.38 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.19 | |||||
| Operating Margin % | 9.93 | |||||
| Net Margin % | 9.04 | |||||
| FCF Margin % | 10.81 | |||||
| ROE % | 14.1 | |||||
| ROA % | 10.36 | |||||
| ROIC % | 17.13 | |||||
| 3-Year ROIIC % | 20.93 | |||||
| ROC (Joel Greenblatt) % | 32.62 | |||||
| ROCE % | 18.8 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.1 | |||||
| PE Ratio without NRI | 31.1 | |||||
| Price-to-Owner-Earnings | 19.08 | |||||
| PEG Ratio | 3.27 | |||||
| PS Ratio | 2.81 | |||||
| PB Ratio | 4.1 | |||||
| Price-to-Tangible-Book | 4.18 | |||||
| Price-to-Free-Cash-Flow | 25.99 | |||||
| Price-to-Operating-Cash-Flow | 17 | |||||
| EV-to-EBIT | 20.76 | |||||
| EV-to-EBITDA | 17.24 | |||||
| EV-to-Revenue | 2.53 | |||||
| EV-to-FCF | 23.77 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.38 | |||||
| Price-to-Graham-Number | 2.44 | |||||
| Price-to-Net-Current-Asset-Value | 7.31 | |||||
| Price-to-Net-Cash | 66.27 | |||||
| Earnings Yield (Greenblatt) % | 4.82 | |||||
| FCF Yield % | 3.81 | |||||
| Forward Rate of Return (Yacktman) % | 10.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Windlas Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,592.52 | ||
| EPS (TTM) (₹) | 28.54 | ||
| Beta | 0.69 | ||
| Volatility % | 32.76 | ||
| 14-Day RSI | 59.21 | ||
| 14-Day ATR (₹) | 37.67389 | ||
| 20-Day SMA (₹) | 864.01 | ||
| 12-1 Month Momentum % | 128.37 | ||
| 52-Week Range (₹) | 311.6 - 952.1 | ||
| Shares Outstanding (Mil) | 20.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Windlas Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Windlas Biotech Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Windlas Biotech Ltd Frequently Asked Questions
What is Windlas Biotech Ltd(NSE:WINDLAS)'s stock price today?
The current price of NSE:WINDLAS is ₹895.30. The 52 week high of NSE:WINDLAS is ₹952.10 and 52 week low is ₹311.60.
When is next earnings date of Windlas Biotech Ltd(NSE:WINDLAS)?
The next earnings date of Windlas Biotech Ltd(NSE:WINDLAS) is .
Does Windlas Biotech Ltd(NSE:WINDLAS) pay dividends? If so, how much?
The Dividend Yield %  of Windlas Biotech Ltd(NSE:WINDLAS) is 0.45% (As of Today), Highest Dividend Payout Ratio of Windlas Biotech Ltd(NSE:WINDLAS) was 0.18. The lowest was 0.14. And the median was 0.16. The  Forward Dividend Yield % of Windlas Biotech Ltd(NSE:WINDLAS) is 0.62%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers